Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin.

Source:http://linkedlifedata.com/resource/pubmed/id/9811894

Proc. Natl. Acad. Sci. U.S.A. 1998 Nov 10 95 23 13875-80

Download in:

View as

Triples

General Info

PMID
9811894